Related Experiment Video
Updated: Aug 2, 2026
08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Prospects for cellular immunotherapy for metastatic melanoma
1Department of Surgery, Duke University Medical Center, Durham, NC.
Annals of Plastic Surgery
|January 11, 1992
Summary
Systemic therapy for metastatic melanoma is challenging. Research explores harnessing the human immune system, specifically cellular immunotherapy, to effectively target and eradicate melanoma tumors.
Area of Science:
- Immunology
- Oncology
- Cancer Research
Background:
- Metastatic malignant melanoma treatment outcomes remain poor.
- The human immune system shows a cellular response to melanoma, but T cells often fail to eliminate tumors in disseminated disease.
- Spontaneous melanoma regression suggests the immune system's potential to eradicate established tumors.
Purpose of the Study:
- To investigate the interaction between melanoma and the human immune system.
- To explore alternative therapeutic strategies for metastatic melanoma.
- To evaluate the potential of adoptive immunotherapy in combating melanoma.
Main Methods:
- Documenting cellular immune responses to melanoma in vitro and in vivo.
- Investigating specific and nonspecific adoptive immunotherapy approaches.
- Generating tumor-activated specific killer cells from various patient tissue sources.
Main Results:
- A cellular immune response to melanoma is observable.
- T cells frequently fail to eradicate tumors in patients with disseminated melanoma.
- Tumor-activated killer cells can be generated for potential therapeutic application.
Conclusions:
- The human immune system holds potential for eradicating established melanoma tumors.
- Advances in understanding antigen recognition and T-cell culture are crucial for developing effective cellular immunotherapy.
- Adoptive immunotherapy represents a promising avenue for treating patients with melanoma.
